Ocular Surgery News U.S. Edition Current Issue
The following articles appeared in the print edition of Ocular Surgery News U.S. Edition.
Table of Contents
- Emerging technologies open new horizons in glaucoma structural evaluation, management
-
- DMEK graft rejection rate low with prednisolone acetate or fluorometholone
- Drainage devices yield mixed results in eyes with post-keratoplasty glaucoma
- Intraoperative OCT may affect decisions made during vitreomacular traction surgery
- Meta-analysis finds lipids and lipid genes do not influence incidence, progression of AMD
- Oraya receives grant to investigate gold nanoparticles
- Quick procedure tests integrity of cataract surgery wounds Steven B. Siepser, MD, FACS
- Target IOP a key issue in glaucoma management, reduction of costs
- What does the patient see? Uday Devgan, MD
-
- Optimization of ocular surface requires newer treatment options
- Man referred for acute onset of distortions, decreased vision Geetha Athappilly, MD; Kristen E. Dunbar, MD
- Refractive lenticule extraction yields stable visual, refractive outcomes at 5 years
- Numbers help tell the story of glaucoma diagnosis, treatment Richard L. Lindstrom, MD
- Alcon launches three additions to vitreoretinal surgical portfolio
- Direct-to-consumer genetic tests for AMD risk assessment far from reliable
- IOP increase seen with Ozurdex common but easily managed
- Kreissig Award Lecture highlights AMD research milestones
-
- LUCAS study shows equivalence between anti-VEGF drugs following inject-and-extend regimen
- New INTREPID trial data dispel concerns of radiation-induced microvascular lesions
- Ozurdex effective for treatment of RVO in clinical practice
- Ozurdex offers better anatomic outcomes, similar visual acuity vs. anti-VEGF
- ‘Real-life’ study provides data for anti-VEGF treatment in diverse RVO population
- Regression in drusen volume predictive of disease progression
- SAKURA 1 study meets primary endpoint for treatment of noninfectious uveitis
- US database may show difference in risk rates between anti-VEGFs
-
- Vascularization key to RPE choroid transplantation
- How to best incorporate Restasis in treating dry eye syndrome Darrell E. White, MD